Dongbing CUI

City:

Shanghai

Country:

China

Published Applications:

Last publication date:

2026-06-04

Top Assignees for applications by Dongbing CUI

The entities that hold a legal rights for patent applications filed by inventor CUI Dongbing:

JIANGSU HENGRUI MEDICINE CO., LTD. 5 Lianyungang, Jiangsu, China
SHANGHAI HENGRUI PHARMACEUTICAL CO. LTD. 5 Shanghai, China
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 2 Jiangsu, China
Shanghai Hengrui Pharmaceutical Co., Ltd. 1 Minhang District, Shanghai, China
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 1 Suzhou, JIangsu, China
JIANGSU HENGRUI MEDICINE CO. LTD. 1 Lianyungang, China

Recent patent applications by CUI Dongbing

Dongbing CUI from Shanghai, CN has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-06-04

US20260152552A1

Chemistry; metallurgy

NOVEL ANTI-L1CAM ANTIBODY

#2 | 2021-04-15

US20210106655A1

Human necessities

Interleukin 15 protein complex and use thereof

#3 | 2020-12-24

US20200399375A1

Chemistry; metallurgy

PD-L1 antibody, antigen-binding fragment thereof and medical application thereof

#4 | 2020-08-27

US20200270365A1

Chemistry; metallurgy

PCSK9 ANTIBODY, ANTIGEN-BINDING FRAGMENT THEREOF, AND MEDICAL USES THEREOF

#5 | 2019-03-07

US20190070264A1

Human necessities

Interleukin 15 protein complex

#6 | 2019-01-17

US20190016825A1

Chemistry; metallurgy

PCSK9 antibody, antigen-binding fragment thereof, and medical application thereof

#7 | 2018-11-22

US20180334504A1

Chemistry; metallurgy

PD-L1 antibody, antigen-binding fragment thereof and medical application thereof

#8 | 2018-04-26

US20180110875A1

Human necessities

Anti-c-Met antibody and anti-c-Met antibody-cytotoxic drug conjugate and pharmaceutical use thereof

#9 | 2018-04-12

US20180099046A1

Human necessities

Anti-sclerostin antibody, antigen binding fragment and medical use thereof

InventorID:

2160656 ⎘